日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Phase I dose escalation study of lestaurtinib in patients with myelofibrosis

lestaurtinib治疗骨髓纤维化患者的I期剂量递增研究

Hexner, Elizabeth O; Mascarenhas, John; Prchal, Josef; Roboz, Gail J; Baer, Maria R; Ritchie, Ellen K; Leibowitz, David; Demakos, Erin P; Miller, Crystal; Siuty, James; Kleczko, Jill; Price, Leah; Jeschke, Grace; Weinberg, Rona; Basu, Titiksha; Pahl, Heike L; Orazi, Attilio; Najfeld, Vesna; Marchioli, Roberto; Goldberg, Judith D; Silverman, Lewis R; Hoffman, Ronald

Single agent bevacizumab for myelofibrosis: results of the Myeloproliferative Disorders Research Consortium Trial

单药贝伐单抗治疗骨髓纤维化:骨髓增生性疾病研究联盟试验结果

Mesa, Ruben A; Silver, Richard T; Verstovsek, Srdan; Mascarenhas, John; Kessler, Craig M; Rondelli, Damiano; Goldberg, Judy D; Marchioli, Roberto; Demakos, Erin P; Silverman, Lewis R; Hoffman, Ronald